Skip to content

Clinical Study on Microorganism Brain-gut-axis Mechanism from the Changes of Intestinal Microflora in Insomnia Patients belonging to the Spleen Deficiency

Clinical Study on Microorganism Brain-gut-axis Mechanism from the Changes of Intestinal Microflora in Insomnia Patients belonging to the Spleen Deficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011493
Enrollment
Unknown
Registered
2017-05-26
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non organic insomnia

Interventions

Buzhong Yiqi Tang Group:Granule of Buzhong Yiqi Tang
Control group:Placebo granule of Buzhong Yiqi Tang

Sponsors

Guangdong Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the western medicine diagnostic criteria of insomnia; 2. sleep latencyis over 30 minutes, and/or wake up at night more than 2 times per night, and/or the total sleep time<6 hours. Duration of those symptoms are more than 1 months; 3. Conform to the diagnostic criteriaof insomnia in TCM; 4. Conform to the differentiation standard of spleen and stomach qi deficiency syndrome; 5. Score of PSQI is between 7 to 21; 6. Aged 18-55 years old; 7. Stable vital signs, conscious, have certain expression and cognitive ability; 8. In the past 2 weeks,did not take sedative hypnotics, antipsychotic drugs, antibiotics, corticosteroids and other drugs; 9. Voluntary trial and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Does not conform to the inclusion criteria; 2. Pregnant or lactating patients; 3. Infection and fever in the last week; 4. Participated in other clinical trials in the past three months; 5. Previous history of gastrointestinal disease or gastrointestinal surgery.Patients with severe primary diseases such as cardiovascular, pulmonary, liver, kidney and hematopoietic systems; 6. Insomnia comorbid depression, anxiety, schizophrenia, mania, the standard score of SAS is=60, the standard score of SDS is=62; 7. Patients with a history of epilepsy, OSAHS, COPD, bipolar disorder, mental retardation, cognitive impairment, restless legs syndrome, etc.; 8. Within 6 months, use antibiotics, corticosteroids,immunomodulator , flora regulator and other drugs; 9. In the past 2 weeks, use sedative hypnotics, antipsychotic drugs,gastrointestinal motility drugs,laxative,antidiarrheal agent and other drugs; 10. BMI=28kg/m2 or BMI18.

Design outcomes

Primary

MeasureTime frame
PSQI reduction rate;

Secondary

MeasureTime frame
ISI;GSRS;the level of blood cortisol;Composition and proportion of intestinal flora;

Countries

China

Contacts

Public ContactLi Yan

Guangdong Provincial Hospital of TCM

janeliyan2002@163.com+86 13556054660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026